SRS Capital Advisors »

Calidi Biotherapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Calidi Biotherapeutics (CLDI) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Calidi Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.9k 37k 0.24

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Blackrock Etf Trust Ishares Us Equit (DYNF)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Blackrock Etf Trust Ii Ishares Intermed (INMU)
Spdr Series Trust State Street Spd (TFI)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
NVIDIA Corporation (NVDA)
Blackrock Etf Trust Ishares Us Thema (THRO)
Eldridge Bbb-b Clo Etf Etf (CLOZ)
Vanguard Index Fds Mid Cap Etf (VO)

View all positions for SRS Capital Advisors

Top funds holding Calidi Biotherapeutics

Armistice Capital
Warberg Asset Management
HighTower Advisors
Geode Capital Management
Rs Crum
SRS Capital Advisors
Jane Street
Vanguard Group
Vanguard Capital Management
FMR
Virtu Financial
Belpointe Asset Management
Northern Trust
Hrt Financial
Farther Finance Advisors

View all funds holding Calidi Biotherapeutics